Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.25
-0.05 (-1.03%)
Apr 20, 2026, 12:56 PM EDT - Market open
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.33 million as of April 20, 2026. Its market cap has decreased by -56.11% in one year.
Market Cap
13.33M
Enterprise Value
1.65M
1-Year Change
-56.11%
Ranking
Category
Stock Price
$5.25
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.33M, a decrease of -79.81%. That is a compound annual growth rate of -43.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 13.46M | -45.35% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 14.18M |
| Hoth Therapeutics | 13.96M |
| Kairos Pharma | 13.10M |
| Cadrenal Therapeutics | 13.09M |
| Moleculin Biotech | 12.91M |
| BioCardia | 12.91M |
| Soligenix | 12.88M |
| Cyclerion Therapeutics | 12.76M |